Melatonin Ameliorates Injury and Specific Responses of Ischemic Striatal Neurons in Rats

Journal of Histochemistry and Cytochemistry

Volumn 61, Issue 8, 2013, Pages 591-605

  Ma, Yuxin ^a,b   Feng, Qiqi ^a   Ma, Jing ^c   Feng, Zhibo ^d   Zhan, Mali ^a   OuYang, Lisi ^a   Mu, Shuhua ^a   Liu, Bingbing ^a   Jiang, Zhuyi ^a   Jia, Yu ^a   Li, Youlan ^a   Lei, Wanlong ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b GUANGDONG PHARMACEUTICAL UNIVERSITY   (China)

^c Xintang Hospital   (China)

^d XINXIANG MEDICAL UNIVERSITY   (China)

Author keywords

interneuron; MCAO; melatonin; projection neuron; striatum

Indexed keywords

CALRETININ; CHOLINE ACETYLTRANSFERASE; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR 1; DOPAMINE RECEPTOR 2; MELATONIN; NEUROPEPTIDE Y; PARVALBUMIN; PHOSPHOPROTEIN DARPP 32; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BRAIN INFARCTION; CELL DENSITY; CELL TYPE; COGNITION; CONTROLLED STUDY; COORDINATION; CORPUS STRIATUM; HISTOLOGY; INTERNEURON; LOCOMOTION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MORPHOLOGY; NERVE CELL LESION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT;

INTERNEURON; MCAO; MELATONIN; PROJECTION NEURON; STRIATUM;

ANIMALS; BEHAVIOR, ANIMAL; CORPUS STRIATUM; MALE; MELATONIN; NEURONS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84887344033     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1369/0022155413492159     Document Type: Article

References (71)

1. Avendano C,Roda JM,Carceller F,Diez-Tejedor E.Morphometric study of focal cerebral ischemia in rats: a stereological evaluation.Brain Res. 1995;673:83-92.
2. Bacigaluppi M,Comi G,Hermann DM.Animal models of ischemic stroke. Part two: modeling cerebral ischemia.Open Neurol J. 2010;4:34-38.
3. Berke JD.Functional properties of striatal fast-spiking interneurons.Front Syst Neurosci. 2011;5:45.
4. Block F,Dihne M,Loos M.Inflammation in areas of remote changes following focal brain lesion.Prog Neurobiol. 2005;75:342-365.
5. Brouillet E,Jacquard C,Bizat N,Blum D.3-nitropropionic acid: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington's disease.J Neurochem. 2005;95:1521-1540.
6. Camacho ME,Carrion MD,Lopez-Cara LC,Entrena A,Gallo MA,Espinosa A,Escames G,Acuna-Castroviejo D.Melatonin synthetic analogs as nitric oxide synthase inhibitors.Mini Rev Med Chem. 2012;12:600-617.
7. Carmichael ST.Rodent models of focal stroke: size, mechanism, and purpose.NeuroRx. 2005;2:396-409.
8. Cervantes M,Morali G,Letechipia-Vallejo G.Melatonin and ischemia-reperfusion injury of the brain.J Pineal Res. 2008;45:1-7.
9. Chesselet MF,Gonzales C,Lin CS,Polsky K,Jin BK.Ischemic damage in the striatum of adult gerbils: relative sparing of somatostatinergic and cholinergic interneurons contrasts with loss of efferent neurons.Exp Neurol. 1990;110:209-218.
10. Chuhma N,Tanaka KF,Hen R,Rayport S.Functional connectome of the striatal medium spiny neuron.J Neurosci. 2011;31:1183-1192.
11. Cicchetti F,Gould PV,Parent A.Sparing of striatal neurons coexpressing calretinin and substance P (NK1) receptor in Huntington's disease.Brain Res. 1996;730:232-237.
12. Cicchetti F,Prensa L,Wu Y,Parent A.Chemical anatomy of striatal interneurons in normal individuals and in patients with Huntington's disease.Brain Res Brain Res Rev. 2000;34:80-101.
13. Covey MV,Oorschot DE.Effect of hypothermic post-treatment on hypoxic-ischemic striatal injury, and normal striatal development, in neonatal rats: a stereological study.Pediatr Res. 2007;62:646-651.
14. Cowan RL,Wilson CJ,Emson PC,Heizmann CW.Parvalbumin-containing GABAergic interneurons in the rat neostriatum.J Comp Neurol. 1990;302:197-205.
15. Dirnagl U,Iadecola C,Moskowitz MA.Pathobiology of ischaemic stroke: an integrated view.Trends Neurosci. 1999;22:391-397.
16. Dolga AM,Terpolilli N,Kepura F,Nijholt IM,Knaus HG,D'Orsi B,Prehn JH,Eisel UL,Plant T,Plesnila N,Culmsee C.KCa2 channels activation prevents [Ca2+]i deregulation and reduces neuronal death following glutamate toxicity and cerebral ischemia.Cell Death Dis. 2011;2:e147.
17. Donnan GA,Fisher M,Macleod M,Davis SM.Stroke.Lancet. 2008;371:1612-1623.
18. Durieux PF,Schiffmann SN,de Kerchove DA.Targeting neuronal populations of the striatum.Front Neuroanat. 2011;5:40.
19. El MN,Cheruel F,Faure A,Conde F.Learning and memory dissociation in rats with lesions to the subthalamic nucleus or to the dorsal striatum.Neuroscience. 2007;147:906-918.
20. Figueredo-Cardenas G,Harris CL,Anderson KD,Reiner A.Relative resistance of striatal neurons containing calbindin or parvalbumin to quinolinic acid-mediated excitotoxicity compared to other striatal neuron types.Exp Neurol. 1998;149:356-372.
21. Goto S,Nagahiro S,Korematsu K,Ushio Y.Striatonigral involvement following transient focal cerebral ischemia in the rats: an immunohistochemical study on a reversible ischemia model.Acta Neuropathol. 1993;85:515-520.
22. Guadagno JV,Warburton EA,Aigbirhio FI,Smielewski P,Fryer TD,Harding S,Price CJ,Gillard JH,Carpenter TA,Baron JC.Does the acute diffusion-weighted imaging lesion represent penumbra as well as core? A combined quantitative PET/MRI voxel-based study.J Cereb Blood Flow Metab. 2004;24:1249-1254.
23. Han I,You Y,Kordower JH,Brady ST,Morfini GA.Differential vulnerability of neurons in Huntington's disease: the role of cell type-specific features.J Neurochem. 2010;113:1073-1091.
24. Hyakkoku K,Nakajima Y,Izuta H,Shimazawa M,Yamamoto T,Shibata N,Hara H.Thalidomide protects against ischemic neuronal damage induced by focal cerebral ischemia in mice.Neuroscience. 2009;159:760-769.
25. Kawaguchi Y.Physiological, morphological, and histochemical characterization of three classes of interneurons in rat neostriatum.J Neurosci. 1993;13:4908-4923.
26. Kilic E,Kilic U,Reiter RJ,Bassetti CL,Hermann DM.Prophylactic use of melatonin protects against focal cerebral ischemia in mice: role of endothelin converting enzyme-1.J Pineal Res. 2004a;37:247-251.
27. Kilic E,Kilic U,Yulug B,Hermann DM,Reiter RJ.Melatonin reduces disseminate neuronal death after mild focal ischemia in mice via inhibition of caspase-3 and is suitable as an add-on treatment to tissue-plasminogen activator.J Pineal Res. 2004b;36:171-176.
28. Koh PO.Melatonin attenuates the cerebral ischemic injury via the MEK/ERK/p90RSK/bad signaling cascade.J Vet Med Sci. 2008;70:1219-1223.
29. Koh PO.Melatonin attenuates decrease of protein phosphatase 2A subunit B in ischemic brain injury.J Pineal Res. 2012;52:57-61.
30. Kokaia Z,Andsberg G,Martinez-Serrano A,Lindvall O.Focal cerebral ischemia in rats induces expression of P75 neurotrophin receptor in resistant striatal cholinergic neurons.Neuroscience. 1998;84:1113-1125.
31. Kondoh T,Uneyama H,Nishino H,Torii K.Melatonin reduces cerebral edema formation caused by transient forebrain ischemia in rats.Life Sci. 2002;72:583-590.
32. Kreitzer AC,Berke JD.Investigating striatal function through cell-type-specific manipulations.Neuroscience. 2011;198:19-26.
33. Larsson E,Lindvall O,Kokaia Z.Stereological assessment of vulnerability of immunocytochemically identified striatal and hippocampal neurons after global cerebral ischemia in rats.Brain Res. 2001;913:117-132.
34. Lee CH,Yoo KY,Choi JH,Park OK,Hwang IK,Kwon YG,Kim YM,Won MH.Melatonin's protective action against ischemic neuronal damage is associated with up-regulation of the MT2 melatonin receptor.J Neurosci Res. 2010;88:2630-2640.
35. Liu F,Schafer DP,McCullough LD.TTC, fluoro-Jade B and NeuN staining confirm evolving phases of infarction induced by middle cerebral artery occlusion.J Neurosci Methods. 2009;179:1-8.
36. Liu S,Levine SR,Winn HR.Targeting ischemic penumbra: part I-from pathophysiology to therapeutic strategy.J Exp Stroke Transl Med. 2010;3:47-55.
37. Maldonado MD,Murillo-Cabezas F,Terron MP,Flores LJ,Tan DX,Manchester LC,Reiter RJ.The potential of melatonin in reducing morbidity-mortality after craniocerebral trauma.J Pineal Res. 2007;42:1-11.
38. Mallard EC,Waldvogel HJ,Williams CE,Faull RL,Gluckman PD.Repeated asphyxia causes loss of striatal projection neurons in the fetal sheep brain.Neuroscience. 1995;65:827-836.
39. Marston HM,Faber ES,Crawford JH,Butcher SP,Sharkey J.Behavioural assessment of endothelin-1 induced middle cerebral artery occlusion in the rat.NeuroReport. 1995;6:1067-1071.
40. Matsumori Y,Hong SM,Fan Y,Kayama T,Hsu CY,Weinstein PR,Liu J.Enriched environment and spatial learning enhance hippocampal neurogenesis and salvages ischemic penumbra after focal cerebral ischemia.Neurobiol Dis. 2006;22:187-198.
41. Meade CA,Figueredo-Cardenas G,Fusco F,Nowak TJ,Pulsinelli WA,Reiner A.Transient global ischemia in rats yields striatal projection neuron and interneuron loss resembling that in Huntington's disease.Exp Neurol. 2000;166:307-323.
42. Mu S,OuYang L,Liu B,Qu H,Zhu Y,Li K,Lei W.Relationship between inflammatory reaction and ischemic injury of caudate-putamen in rats: inflammatory reaction and brain ischemia.Anat Sci Int. 2011a;86:86-97.
43. Mu S,OuYang L,Liu B,Zhu Y,Li K,Zhan M,Liu Z,Jia Y,Lei W.Protective effect of melatonin on 3-NP induced striatal interneuron injury in rats.Neurochem Int. 2011b;59:224-234.
44. Mu S,OuYang L,Liu B,Zhu Y,Li K,Zhan M,Liu Z,Jia Y,Lei W,Reiner A.Preferential interneuron survival in the transition zone of 3-NP-induced striatal injury in rats.J Neurosci Res. 2011c;89:744-754.
45. Mullen RJ,Buck CR,Smith AM.NeuN, a neuronal specific nuclear protein in vertebrates.Development. 1992;116:201-211.
46. Mura A,Feldon J,Mintz M.The expression of the calcium binding protein calretinin in the rat striatum: effects of dopamine depletion and L-DOPA treatment.Exp Neurol. 2000;164:322-332.
47. Nair SM,Rahman RM,Clarkson AN,Sutherland BA,Taurin S,Sammut IA,Appleton I.Melatonin treatment following stroke induction modulates L-arginine metabolism.J Pineal Res. 2011;51:313-323.
48. Nishino H,Koide K,Aihara N,Kumazaki M,Sakurai T,Nagai H.Striatal grafts in the ischemic striatum improve pallidal GABA release and passive avoidance.Brain Res Bull. 1993;32:517-520.
49. Oda Y.Choline acetyltransferase: the structure, distribution and pathologic changes in the central nervous system.Pathol Int. 1999;49:921-937.
50. Ouimet CC,Greengard P.Distribution of DARPP-32 in the basal ganglia: an electron microscopic study.J Neurocytol. 1990;19:39-52.
51. Packard MG,Knowlton BJ.Learning and memory functions of the Basal Ganglia.Annu Rev Neurosci. 2002;25:563-593.
52. Pei Z,Ho HT,Cheung RT.Pre-treatment with melatonin reduces volume of cerebral infarction in a permanent middle cerebral artery occlusion stroke model in the rat.Neurosci Lett. 2002a;318:141-144.
53. Pei Z,Pang SF,Cheung RT.Pretreatment with melatonin reduces volume of cerebral infarction in a rat middle cerebral artery occlusion stroke model.J Pineal Res. 2002b;32:168-172.
54. Pestalozza IF,Di Legge S,Calabresi M,Lenzi GL.Ischaemic penumbra: highlights.Clin Exp Hypertens. 2002;24:517-529.
55. Quay WB.Changes with darkness in regional brain 5-hydroxytryptamine and 5-hydroxyindole acetic acid: local differences with pinealectomy, sham surgery, and melatonin.Neurochem Res. 1989;14:957-961.
56. Reiter RJ,Cabrera J,Sainz RM,Mayo JC,Manchester LC,Tan DX.Melatonin as a pharmacological agent against neuronal loss in experimental models of Huntington's disease, Alzheimer's disease and parkinsonism.Ann N Y Acad Sci. 1999;890:471-485.
57. Reiter RJ,Oh CS,Fujimori O.Melatonin Its intracellular and genomic actions.Trends Endocrinol Metab. 1996;7:22-27.
58. Reiter RJ,Tan DX,Leon J,Kilic U,Kilic E.When melatonin gets on your nerves: its beneficial actions in experimental models of stroke.Exp Biol Med (Maywood). 2005;230:104-117.
59. Riedel A,Hartig W,Seeger G,Gartner U,Brauer K,Arendt T.Principles of rat subcortical forebrain organization: a study using histological techniques and multiple fluorescence labeling.J Chem Neuroanat. 2002;23:75-104.
60. Sakai N,Yanai K,Ryu JH,Nagasawa H,Hasegawa T,Sasaki T,Kogure K,Watanabe T.Behavioral studies on rats with transient cerebral ischemia induced by occlusion of the middle cerebral artery.Behav Brain Res. 1996;77:181-188.
61. Shear DA,Dong J,Gundy CD,Haik-Creguer KL,Dunbar GL.Comparison of intrastriatal injections of quinolinic acid and 3-nitropropionic acid for use in animal models of Huntington's disease.Prog Neuropsychopharmacol Biol Psychiatry. 1998;22:1217-1240.
62. Srinivasan V,Pandi-Perumal SR,Maestroni GJ,Esquifino AI,Hardeland R,Cardinali DP.Role of melatonin in neurodegenerative diseases.Neurotox Res. 2005;7:293-318.
63. Tamura A,Graham DI,McCulloch J,Teasdale GM.Focal cerebral ischaemia in the rat: 1. Description of technique and early neuropathological consequences following middle cerebral artery occlusion.J Cereb Blood Flow Metab. 1981;1:53-60.
64. Tan DX,Manchester LC,Terron MP,Flores LJ,Reiter RJ.One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species?.J Pineal Res. 2007;42:28-42.
65. Tepper JM,Tecuapetla F,Koos T,Ibanez-Sandoval O.Heterogeneity and diversity of striatal GABAergic interneurons.Front Neuroanat. 2010;4:150.
66. Uz T,Akhisaroglu M,Ahmed R,Manev H.The pineal gland is critical for circadian Period1 expression in the striatum and for circadian cocaine sensitization in mice.Neuropsychopharmacology. 2003;28:2117-2123.
67. Voogd J,Feirabend HKPMethods in neurobiology. New York: Elsevier; 1981:.
68. Vorhees CV,Williams MT.Morris water maze: procedures for assessing spatial and related forms of learning and memory.Nat Protoc. 2006;1:848-858.
69. Yamori Y,Horie R,Handa H,Sato M,Fukase M.Pathogenetic similarity of strokes in stroke-prone spontaneously hypertensive rats and humans.Stroke. 1976;7:46-53.
70. Yang YF,Chen Z,Hu SL,Hu J,Li B,Li JT,Wei LJ,Qian ZM,Lin JK,Feng H,Zhu G.Interleukin-1 receptor associated kinases-1/4 inhibition protects against acute hypoxia/ischemia-induced neuronal injury in vivo and in vitro.Neuroscience. 2011;196:25-34.
71. Yang Z,You Y,Levison SW.Neonatal hypoxic/ischemic brain injury induces production of calretinin-expressing interneurons in the striatum.J Comp Neurol. 2008;511:19-33.